Abstract
Abstract
Background
Automated dispensing systems (ADSs) for radiopharmaceuticals have been developed to reduce the radiation exposure of personnel, to improve the accuracy of the dispensed dose and to limit the microbiological contamination. However, before implementing such systems, validation according to various applicable guidelines is necessary to ensure safety and quality. Here we present the selection, validation and implementation of the PT459R2 from manufacturer Lynax s.r.o. as a guidance protocol for validation according to GMP and GRPP guidelines. Validation included linearity accuracy and precision of the internal scintillation detector for different isotopes and microbiological validation for aseptic procedures.
Results
The ADS can dispense accurate doses in the following linear range: 1000–10,000 MBq for lutetium-177, 20–74 MBq for zirconium-89, 100–1000 MBq for gallium-68 and 100–2000 MBq for fluorine-18. The maximum bias is 2.35% and the maximum coefficient of variation is 3.03% which meets the acceptance criteria of < 5%. Furthermore, the ADS does not affects the GMP class A environment in a laminar airflow cabinet and can dispense aseptically. In addition, radiation exposure is acceptable and data integrity is preserved.
Conclusion
The PT459R2 ADS met all the requirements from our performance qualification and is therefore suitable for daily routine use in our center. Our approach can be used as a guidance for PQ of an ADS in a Radiopharmacy according to GMP and GRPP guidelines.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Aerts J, Ballinger JR, Behe M, et al. Guidance on current good radiopharmacy practice for the small-scale preparation of radiopharmaceuticals using automated modules: A European perspective. J Labelled Comp Radiopharm. 2014;57(10):615–20. https://doi.org/10.1002/JLCR.3227.
2. Covens P, Berus D, Vanhavere F, Caveliers V. The introduction of automated dispensing and injection during pet procedures: a step in the optimisation of extremity doses and whole-body doses of nuclear medicine staff. Radiat Prot Dosimetry. 2010;140(3):250–8. https://doi.org/10.1093/rpd/ncq110.
3. Council Directive 2013/59/Euratom of 5 December 2013 laying down basic safety standards for protection against the dangers arising from exposure to ionising radiation, and repealing Directives 89/618/Euratom, 90/641/Euratom, 96/29/Euratom, 97/43/Euratom and 2003/122/Euratom.
4. European Commission. EudraLex - The Rules Governing Medicinal Products in the European Union EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use. http://ec.europa.eu/health/documents/eudralex/vol-4/index_en.htm. Accessed November 24, 2023.
5. European Commission. EudraLex—Volume 4. Annex 15. Qualification and validation. Brussels, March 30 2015. https://health.ec.europa.eu/system/files/2016-11/2015-10_annex15_0.pdf. Accessed November 24, 2023.